Products

drMID for Illumina NGS systems - Multiplicom

Molecular identifiers (MIDs) and adaptors of MASTR-based assays

The drMID is an extension of the current MID for Illumina MiSeq kit to make it compatible with all Illumina NGS platforms and is currently supported on MiSeq and NextSeq. The drMID for Illumina NGS systems kit contains the same components as the MID for Illumina MiSeq kit, with the addition of an Index 2 primer. This is extra primer is included to allow reading of the second index sequence (required for Illumina NextSeq, MiniSeq and HiSeq 3000/4000). 

One kit contains 8 specific p7 MID primers and 6 specific p5 MID primers enabling 48 possible p7-p5 MID combinations. The total amount of reactions is 240.

At launch, the following products are supported for combination with the drMID for Illumina NGS systems kit:

  • BRCA Tumor MASTR Plus (RUO)
  • Tumor Hotspot MASTR Plus (RUO)
  • SOMATIC 2 MASTR Plus (RUO)
  • SOMATIC 1 MASTR Plus (RUO)

The updated instructions for the other products will be launched at a later date. At the end of the phase out period, all our currently available products which can be combined with the MID for Illumina MiSeq kits will be supported with the drMID for Illumina NGS systems kit.

The MID for Illumina MiSeq (RUO) kit will be fully replaced with the drMID for Illumina NGS systems (RUO) kit after a phase in/phase out period of 6 months.

Show more

http://www.multiplicom.com/product/drmid-illumina-ngs-systems-1
Petra Kupková

Sales Manager

Petra

Kupková

+420 731 426 051

Send Message

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey